Single‐ and multiple‐dose pharmacokinetics of bosentan and its interaction with ketoconazole

Abstract

The multiple-dose pharmacokinetics of bosentan are consistent with the phenomenon of auto-induction. In the presence of CYP3A4 inhibitors, bosentan concentrations may be increased 2-fold.